Clinical Trial Update: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features [Phase 1]

View source ↗

Summary

A Phase 1 safety study update evaluating Seneca Valley Virus in patients with solid tumors exhibiting neuroendocrine features.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoid Tumor
• Neuroendocrine Tumor

Drugs mentioned

• Seneca Valley Virus (Seneca Valley Virus)

Snippet

Sponsor: Neotropix | Conditions: Carcinoid, Neuroendocrine | Phase 1 | Status: UNKNOWN